Chromogranin a in physiology and oncology

Folia Biologica (Czech Republic)

Volumn 57, Issue 5, 2011, Pages 173-181

  Louthan, O ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

CATECHOLAMINE; CHROMOGRANIN A; CHROMOGRANIN B; CYCLIC AMP DEPENDENT PROTEIN KINASE; PEPTIDE HORMONE; PROTEIN KINASE C; SECRETOGRANIN II; SECRETOGRANIN V; TUMOR MARKER;

ADRENAL MEDULLA; ANTIMICROBIAL ACTIVITY; ATROPHIC GASTRITIS; CANCER PROGNOSIS; CARCINOID; CATECHOLAMINE RELEASE; CELL ADHESION; CHROMAFFIN GRANULE; CONFORMATIONAL TRANSITION; DNA RESPONSIVE ELEMENT; EXOCYTOSIS; FALSE NEGATIVE RESULT; GENE EXPRESSION; GENE LOCATION; HORMONE RELEASE; HUMAN; HYPERTENSION; NEUROSECRETORY CELL; NONHUMAN; ONCOLOGY; OSMOTIC PRESSURE; PHEOCHROMOCYTOMA; PHYSIOLOGY; PROTEIN PROCESSING; REVIEW; SECRETORY GRANULE; SECRETORY VESICLE; SENSITIVITY AND SPECIFICITY; SYMPATHETIC NERVE; TRANS GOLGI NETWORK; TUMOR LOCALIZATION; TUMOR RECURRENCE; AMINO ACID SEQUENCE; ANIMAL; CHROMOSOME 14; ENDOCRINE GLAND; GENE DOSAGE; GENETICS; METABOLISM; MOLECULAR GENETICS; NEUROENDOCRINE TUMOR;

ADRENAL MEDULLA; AMINO ACID SEQUENCE; ANIMALS; CHROMAFFIN GRANULES; CHROMOGRANIN A; CHROMOSOMES, HUMAN, PAIR 14; ENDOCRINE GLANDS; GENE DOSAGE; HUMANS; MOLECULAR SEQUENCE DATA; NEUROENDOCRINE TUMORS; SECRETORY VESICLES; TUMOR MARKERS, BIOLOGICAL;

EID: 84861793334     PISSN: 00155500     EISSN: 25337602     Source Type: Journal    
DOI: None     Document Type: Review

References (28)

1. Barbosa, J. A., Gill, B. M., Takiyyuddin, M. A., O'Connor, D. T. (1991) Chromogranin A: posttranslational modifications in secretory granules. Endocrinology 128, 174-190.
2. Baudin, E., Bidart, J. M., Bachelot, A., Ducreux, M., Elias, D., Ruffie, P., Schlumberger, M. (2001) Impact of chromogranin A measurement in the work-up of neuroendocrine tumours. Ann. Oncol. 12, 879-882.
3. Bilek, R., Šafařik, L., Ciprova, V., Vlček, P., Lisa L. (2008) Chromogranin A, a member of neuroendocrine secretory proteins as a selective marker for laboratory diagnosis of pheochromocytoma. Physiol. Res. 57 (Suppl. 1), 171-179.
4. Deftos, L. J. (1991) Chromogranin A -its role in endocrine function and as endocrine and neuroendocrine tumour marker. Endocr. Rev. 12, 181-187.
5. Degorce, F., Goumon, Y., Jacquemart, L., Vidaud, C., Bellanger, L., Pons-Anicet, D., Sequin, P., Metz-Boutigue, M. H., Aunis, D. (1999) A new human chromogranin A (CgA) immunoradiometric assay involving monoclonal antibodies raised against the unprocessed central domain (145-245). Br. J. Cancer 79, 65-71.
6. D'Herbomez, M., Gouze, V., Huglo, D., Nocaudie, M., Pattou, F., Proye, C., Wemeau, J. L., Marchandise, X. (2001) Chromogranin A assay and (131)I-MIBG scintigraphy for diagnosis and follow-up of pheochromocytoma. J. Nucl. Med. 42, 993-997.
7. Eriksson, B., Oberg, K., Stridsberg, M. (2000) Tumour markers in neuroendocrine tumours. Digestion 62 (Suppl.1), 33-38.
8. Feldman, S. A., Eiden, L. E. (2003) The chromogranins: their roles in secretion from neuroendocrine cells and as markers for neuroendocrine neoplasia. Endocr. Pathol. 14, 3-23.
9. Ferrari, L., Seregni, E., Bajetta, E., Martinetti, A., Bombardieri, E. (1999) The biological characteristic of chromogranin A and its role as a circulating marker in euroendocrine tumours. Anticancer Res. 19, 3415-3428.
10. Gasparri, A., Sidoli, A., Sanchez, L. P., Longhi, R., Siccardi, A. G., Marchisio, P. C., Corti, A. (1997) Chromogranin A fragments modulate cell adhesion. Identification and characterization of a pro-adhesive domain. J. Biol. Chem. 272, 20835-20843.
11. Giovanella, L. C. (2000) Chromogranin A, a circulating neuroendocrine marker. Biological background, analytical methods and clinical applications. Monograph, Schering p. 39.
12. Giovanella, L., Squin, N., Ghelfo, A., Ceriani, L. (2006) Chromogranin A immunoradiometric assay in diagnosis of pheochromocytoma: comparison with plasma metanephrines and 123I-MIBG scan. Q. J. Nucl. Med. Mol. Imaging 50, 344-347.
13. Gonzalez-Yanes, C., Santos-Alvarez, J., Sanchez-Marga. (2001) Pancreastatin, a chromogranin A-derived peptide, activates Gα(16) and phospholipase C-β(2) by interacting with specific receptors in rat heart membranes. Cell. Signal. 13, 43-49.
14. Hendy, G. N., Bevan, S., Mattei, M.-G., Mouland, A. J. (1995) Chromogranin A. Clin. Invest. Med. 18, 47-65.
15. Hsiao, R. A., Mezger, M. S., O'Connor, D. T. (1990) Chromogranin A in uremia: Progressive retention of immunoreactive fragments. Kidney Int. 37, 955-964.
16. Janson, E. T., Holmberg, L., Stridsberg, M. (1997) Carcinoid tumours: Analysis of prognostic factors and survival in 301 patients from a referral center. Ann. Oncol. 8, 685-690.
17. Jiang, Q., Taupenot, L., Mahata, S. K., Mahata, M., ÓConnor, D. T., Miles, L. A., Parmer, R. J. (2001) Proteolytic cleavage of chromogranin A (CgA) by plasmin. Selective liberation of a specific bioactive CgA fragment that regulates catecholamine release. J. Biol. Chem. 276, 25022-25029.
18. Koeslag, J. H., Saunders, P. T., Wessels, J. A. (1999) The chromogranins and the counter-regulatory hormones: do they make homeostatic sense J. Physiol. 517, 643-649.
19. Nobels, F. R., Kwekkeboom, D. J., Bouillon, R., Lamberts, S. W. J. (1998) Chromogranin A: its clinical value as marker of neuroendocrine tumours. Eur. J. Clin. Invest. 28, 431-440.
20. Oberg, K., Tiensuu Janson, E. M., Eriksson, B. (1999) Tumour markers in neuroendocrine tumours. Ital. J. Gastroenterol. Hepatol. 31, (Suppl. 2), 160-162.
21. Rosa, P., Gerdes, H. H. (1994) The granin family: markers for neuroendocrine cells and tools for the diagnosis of neuroendocrine tumours. J. Endocrinol. Invest. 17, 207-225.
22. Schurman, G., Betzler, M., Buhr, H. J. (1990) Chromogranin A, neuron-specific enolase and synaptophysin as neuroendocrine cell markers in the diagnosis of tumours of gastro-entero-pancreatic system. Eur. J. Surg. Oncol. 16, 298-303.
23. Sciola, V., Massironi, S., Conte, D., Caprioli, F., Ferrero, S., Ciafardini, C., Peracchi, M., Bardella, M. T., Piodi, L. (2009) Plasma chromogranin a in patients with inflammatory bowel disease. Inflamm. Bowel Dis. 15, 867-871.
24. Sobol, R. E., Memoli, V., Deftos, L. J. (1989) Hormone-negative, chromogranin A-positive endocrine tumours. N. Engl. J. Med. 320, 444-447.
25. Strub, J. M., Goumon, Y., Lugardon, K., Capon, C., Lopez, M., Moniatte, M., Van Dorsselaer, A., Aunis, D., Metz-Boutigue, M. H. (1996) Antibacterial activity of glycosylated and phosphorylated chromogranin A-derived peptide 173-194 from bovine adrenal medullary chromaffin granules. J. Biol. Chem. 271, 28533-28540.
26. Takiyyudin, M. A., Cervenka, J. H., Hsiao, R. J., Barbosa, J. A., Parmer, R. J., ÓConnor, D. T. (1990) Chromogranin A. Storage and release in hypertension. Hypertension 15, 237-246.
27. Taupenot, L., Harper, K., O'Connor, D. T. (2003) The chromogranin- secretogranin family. N. Engl. J. Med. 348, 1134-1149.
28. Zatelli, M. C., Torta, M., Leon, A., Ambrosio, M. R., Gion, M., Tomassetti, P. (2007) Chromogranin A as a marker of neuroendocrine neoplasia: an Italian Multicenter Study. Endocr. Relat. Cancer, 14, 473-482.